Literature DB >> 19424608

Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines.

Seon-Hui Shim1, Myung-Whun Sung, Seok-Woo Park, Dae Seog Heo.   

Abstract

The family of signal transducers and activators of transcription (STAT) are transcription factors. Among them, STAT1 is associated with an apoptosis pathway, while STAT3 is associated with tumorigenicity in various cancer cells. In order to investigate the primary roles of STAT1 and STAT3 in head and neck squamous cell carcinoma (HNSCC), we blocked STAT3 with two JAK inhibitors: AG490 (JAK2-STAT3 pathway inhibitor) and JAK total inhibitor. When we inhibited STAT3 with AG490, significant cell death was observed. However, in the case of JAK kinase total inhibitor, no cell growth retardation was observed. We focused on the role of STAT1 in this phenomenon. Suppression of STAT1 by si-RNA resulted in increased cell survival. Furthermore, the growth inhibitory effect of AG490 was reduced by treatment with si-RNA of STAT1. These results reveal that STAT1 is required to promote the tumor killing effect of STAT3 inhibition in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424608     DOI: 10.3892/ijmm_00000196

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

Review 1.  Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Authors:  Carolien Boeckx; Marc Baay; An Wouters; Pol Specenier; Jan B Vermorken; Marc Peeters; Filip Lardon
Journal:  Oncologist       Date:  2013-07-02

2.  CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation.

Authors:  Vinit Kumar; Pingyan Cheng; Thomas Condamine; Sridevi Mony; Lucia R Languino; Judith C McCaffrey; Neil Hockstein; Michael Guarino; Gregory Masters; Emily Penman; Fred Denstman; Xiaowei Xu; Dario C Altieri; Hong Du; Cong Yan; Dmitry I Gabrilovich
Journal:  Immunity       Date:  2016-02-16       Impact factor: 31.745

Review 3.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

Review 4.  STAT1 and STAT3 in tumorigenesis: A matter of balance.

Authors:  Lidia Avalle; Sara Pensa; Gabriella Regis; Francesco Novelli; Valeria Poli
Journal:  JAKSTAT       Date:  2012-04-01

5.  A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Authors:  Inès Souissi; Imen Najjar; Laurent Ah-Koon; Pierre Olivier Schischmanoff; Denis Lesage; Stéphanie Le Coquil; Claudine Roger; Isabelle Dusanter-Fourt; Nadine Varin-Blank; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  BMC Cell Biol       Date:  2011-04-12       Impact factor: 4.241

Review 6.  Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications.

Authors:  Shan Jin; Oyungerel Borkhuu; Wuyuntu Bao; Yun-Tian Yang
Journal:  J Clin Med Res       Date:  2016-02-27

Review 7.  JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.

Authors:  Shubhasree Banerjee; Ann Biehl; Massimo Gadina; Sarfaraz Hasni; Daniella M Schwartz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

8.  Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.

Authors:  Ji-Eun Oh; Jeong-Oh Kim; Jung-Young Shin; Xiang-Hua Zhang; Hye-Sung Won; Sang-Hoon Chun; Chan-Kwon Jung; Won-Sang Park; Suk-Woo Nam; Jung-Woo Eun; Jin-Hyoung Kang
Journal:  Int J Oncol       Date:  2013-05-24       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.